Vaxinano is a biotechnology company specialized in preclinical and pharmaceutical development of human
Vaxinano has raised $6.5M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in October 2024.
Vaxinano's investors include Bpifrance, TCD Capital (ex TheClubDeal), Nord France Amorcage, WiSEED, Captech Sante.
Vaxinano is headquartered in Lille, France.
Vaxinano is a biotechnology company specialized in preclinical and pharmaceutical development of human
Vaxinano is at the Venture - Series Unknown stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Vaxinano — Funding & Investors." VCBacked, October 29, 2024, https://www.vcbacked.co/company/vaxinano. Accessed September 29, 2026.
VCBacked. (2024). Vaxinano — Funding & Investors. Retrieved September 29, 2026, from https://www.vcbacked.co/company/vaxinano
{{cite web |title=Vaxinano — Funding & Investors |url=https://www.vcbacked.co/company/vaxinano |website=VCBacked |access-date=September 29, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated